Infectious Dis.

Your Article Summary

See Latest Articles

Antiviral therapy in compensated and decompensated cirrhotic patients with chronic HCV infection
Expert Opinion in Pharmacotherapy, 07/01/09

Iacobellis A et al. - Treatment is only recommended for a well-compensated liver cirrhosis, whereas antiviral therapy is commonly not implemented in cirrhotics with signs of liver decompensation, over the concern that the use of peginterferon and ribavirin might expose patients to severe treatment-related side effects. This review focuses on data available to support both efficacy and safety of antiviral therapy in both compensated and decompensated cirrhotic patients.

Today in Antimicrobials...keeping you current

Receive free subspecialty "5-minute updates" via email

A Randomized, Double-Blind Study Examining the Comparative Efficacies and Safety of Inhaled Epinephrine and Nasal Decongestant in Hospitalized Infants With Acute Bronchiolitis
The Pediatric Infectious Disease Journal, 11/17/09

Acyclovir: a new use for an old drug
Current Opinion in Infectious Diseases, 10/28/09

H1N1 Vaccine Production, Availability Increasing Slowly
American Family Physician, 11/02/09

See All of Antimicrobials

Today in Hepatitis...keeping you current

Receive free subspecialty "5-minute updates" via email

Management of chronic hepatitis C patients who have relapsed or not responded to pegylated interferon alfa plus ribavirin
Journal of Viral Hepatitis, 11/09/09

Silent Epidemic of Viral Hepatitis May Lead to Boom in Serious Liver Disease
JAMA, 11/12/09

Bone Mineral Density and Serum Levels of Soluble Tumor Necrosis Factors, Estradiol, and Osteoprotegerin in Postmenopausal Women with Cirrhosis after Viral Hepatitis
Journal of Clinical Endocrinology and Metabolism, 11/18/09

See All of Hepatitis